• Silencing GULP1 Gene Aids Ovarian Cancer Progression, Study Suggests
  • Phase 2 Trial Shows Dalantercept Has Limited Effectiveness in Ovarian Cancer Patients
  • Collaboration Tests TRX518-Bavencio Combo in Phase 1/2 Trial of Solid Tumors
  • Women Who Had Assisted Reproduction at Greater Risk of Ovarian, Breast Cancers, Study Says
  • Adding TTFields to Taxol May Help Recurrent Ovarian Cancer Patients, Study Shows
  • Zai Lab Starts Phase 3 Trial of ZL-2306 as First-Line Maintenance Therapy for Ovarian Cancer
  • Loss of Certain Protein Identified in Ovarian Cancer Resistance to PARP Inhibitors
  • Lynparza Maintenance for Ovarian Cancer Takes No Toll on Quality of Life, Study Shows
  • Post-diagnosis Use of Anti-Inflammatory Meds May Improve Ovarian Cancer-specific Survival, Study Suggests
  • Phase 1/2 Trial Begins on ONCOS-102, Imfinzi Combination in Advanced Ovarian, Colorectal Cancers
  • Lynparza Maintenance Delays Disease Progression in Advanced Ovarian Cancer, Phase 3 Trial Shows
  • Artificial Ovary Might Help Women Conceive After Ovarian Cancer Treatment, Study Reports